Interleukin-2 in Metastatic Melanoma

NCT01702896 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped PI Decision

Conditions

Melanoma Metastatic

Interventions

DRUG: Interleukin-2

Sponsor

Western Regional Medical Center